Particle size and zeta potential analyzers (DLS, NTA)

01Overview and value chain#

Markers EC: ISO 22412 (DLS) / ISO 13320 (laser diffraction) + US FDA 21 CFR Part 11 for GxP release testing | OECD: Bio-pharmaceuticals | Regulator: FDA (USA), EMA (EU), NMPA (China)

Particle size and zeta potential analyzers are bench-top instruments that characterize the size distribution, concentration and surface charge of particles suspended in a liquid — from sub-10-nanometer proteins and lipid nanoparticles (LNPs) up to millimeter-scale powders and emulsion droplets. Four measurement principles cover this range: dynamic light scattering (DLS) infers hydrodynamic diameter from Brownian-motion-driven intensity fluctuations, typically 0.3 nm to 10 microns; laser diffraction measures the angular scattering pattern of a bulk ensemble across roughly 10 nanometers to 3.5 millimeters; nanoparticle tracking analysis (NTA) images and tracks individual particles under a laser sheet to report both size and true particle concentration, the method of choice for extracellular vesicles (EVs) and viral particles; and multi-angle light scattering (MALS), coupled downstream of a chromatography column, delivers an absolute (calibration-free) molecular weight. The mRNA-LNP vaccine platform made DLS and NTA release-critical overnight: a Zetasizer-class instrument reports the polydispersity index (PdI, typically targeted below 0.2) and zeta potential (commonly –10 to +10 mV for a stable LNP) that gate batch release, while an EV-characterization workflow depends on NTA’s single-particle count to distinguish true vesicles from protein aggregate co-isolates.

The key directions of particle size and zeta potential analysis are:

1. Dynamic light scattering with integrated zeta potential (DLS + Zeta): combined size, concentration and surface-charge measurement in one optical bench, the default QC instrument for LNP and protein-formulation release.
2. Laser diffraction (Laser Diffraction): ensemble sizing from nanometers to millimeters for powders, emulsions and suspensions, the workhorse for pharmaceutical excipients and industrial particulates.
3. Nanoparticle tracking analysis (NTA): single-particle video tracking that reports true particle concentration (particles/mL) alongside size, the standard for extracellular-vesicle and viral-vector characterization.
4. Multi-angle light scattering coupled to chromatography (SEC-MALS): absolute molecular-weight determination for proteins and polymers without column-calibration assumptions, run in-line after size-exclusion or field-flow fractionation.

Sectoral value chain#

[Sample prep] ──> [Optical bench: laser + detector] ──> [Signal: autocorrelation/diffraction/tracking] ──> [Size/charge/MW distribution]
                                                                  │
                                                          (GxP release record)
                                                                  │
                                                                  ▼
[Batch disposition / formulation decision] <─── [Software: cumulants, CONTIN, or ML fit]

Value chain levels#

Cross-cutting technologies of the sector:

• Backscatter (NIBS) optics: non-invasive back-scatter detection reduces multiple scattering and stray light, extending usable concentration range for turbid samples.
• Microfluidic and flow-cell sampling: automated plate-reader and flow-through formats cut manual handling for high-throughput formulation screening.
• Machine-learning-assisted deconvolution: newer software fits multimodal or polydisperse distributions beyond classical cumulants, improving resolution for mixed LNP/aggregate populations.

02US#

The US market is pulled by mRNA-LNP vaccine and cell-and-gene-therapy manufacturing, where DLS and NTA sit directly in the GxP release pathway, and by a dense instrument-vendor and distributor base serving that demand.

mRNA-LNP release testing, biologics aggregate QC, EV/viral-vector characterization#

• Wyatt Technology (part of Waters Corporation): DynaPro Plate Reader III automates DLS across microplates for high-throughput formulation screening, and the omniDAWN MALS photometer couples to UPLC/UHPLC for absolute molecular-weight determination of proteins and polymers.
• Beckman Coulter (Danaher): the Multisizer 4e Coulter counter sizes and counts particles from 0.2 to 1,600 microns by electrical-impedance sensing, and the LS 13 320 XR laser-diffraction analyzer extends ensemble sizing from 10 nanometers to 3,500 microns with PIDS (polarization intensity differential scattering) for the sub-micron tail.
• Micromeritics: the Saturn DigiSizer laser-diffraction platform and the Empyrean Nano Edition hybrid X-ray scattering system extend bench-top particle characterization into small-angle X-ray scattering (SAXS) for nanomaterial structure beyond light-scattering methods.

03CN#

No China-headquartered vendor cleared this screening round with confirmed, on-domain evidence; China’s demand is driven by a fast-growing domestic biologics and mRNA-vaccine manufacturing base, currently served largely through the same US and European instrument makers’ China distribution and service networks rather than by an independent domestic platform.

import-dependent instrumentation, domestic biologics QC demand, distributor-served market#

• US/EU vendor distribution: Malvern Panalytical, Wyatt Technology, Anton Paar and Beckman Coulter each maintain China sales and applications-support organizations serving domestic biopharma and materials manufacturers.
• Domestic biologics build-out: China’s expanding mRNA-vaccine and monoclonal-antibody manufacturing capacity is the main demand driver for DLS/NTA release testing, without a confirmed domestic instrument originator identified in this screen.
• Screening note: two candidate China-headquartered instrument makers were probed and neither returned confirming, on-domain evidence this round — not asserted as absent, only as unconfirmed.

04EU#

Europe hosts the sector’s historical instrument-engineering base — UK, Austria and Germany each contribute a distinct measurement principle — serving both regional biologics manufacturing and global export.

DLS/zeta-potential origination, dynamic image analysis, nanoparticle tracking for EVs/LNPs#

• Malvern Panalytical (UK): the Zetasizer family (Lab, Pro, Ultra) is the reference DLS-plus-zeta-potential platform for LNP and biologic-formulation release, combining size, concentration and charge measurement with NIBS backscatter optics.
• Anton Paar (Austria): the Litesizer series adds dynamic image analysis (DIA) alongside DLS, extending characterization from nanometer particles to millimeter-scale objects on one platform.
• Particle Metrix (Germany): the ZetaView Evolution nanoparticle tracking analyzer is positioned specifically for extracellular vesicles, lipid nanoparticles, viruses and synthetic nanocarriers, reporting size, concentration, zeta potential and multi-channel fluorescence in one measurement.

05Leading companies and research institutes#

06Tech stack and innovations#

The stack layers four measurement physics on a common software and compliance backbone, with the choice of principle driven by particle size, concentration and whether true particle counting (versus ensemble averaging) is required.

1. Dynamic light scattering (DLS):
   • Autocorrelates intensity fluctuations from Brownian motion; back-scatter (173°/NIBS) geometry cuts multiple scattering in turbid samples.
   • Reports the Z-average hydrodynamic diameter and polydispersity index (PdI) that gate LNP batch release, typically alongside a PdI specification under 0.2.
2. Nanoparticle tracking analysis (NTA):
   • A laser sheet illuminates individual particles under dark-field video microscopy; software tracks each particle’s Brownian displacement frame-by-frame.
   • Reports true particle concentration (particles per mL) independent of optical intensity — the metric an EV or viral-vector potency assay needs that DLS cannot provide on its own.
3. Multi-angle light scattering (MALS) and laser diffraction:
   • MALS, coupled after SEC or field-flow fractionation, measures scattering at multiple angles to derive absolute molecular weight without a column-calibration standard.
   • Laser diffraction inverts a bulk angular-scattering pattern (Mie or Fraunhofer theory) to a volume-weighted size distribution spanning nanometers to millimeters in one scan.

07Value chains and production pipelines#

Industrial pipeline of an LNP/biologic particle-characterization release run (ISO 22412 / 21 CFR Part 11)#

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Sample dilution/filter │ ───> │ 2. Instrument loading      │
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Zeta potential measure │ <─── │ 3. Size/count measurement  │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Software fit & PdI/MW  │ ───> │ 6. GxP report & disposition│
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Sample dilution and filtration

The raw LNP, protein or EV suspension is diluted into the instrument’s valid concentration window (commonly 0.1–1 mg/mL for DLS) and pre-filtered to remove dust that would otherwise dominate the scattering signal.

Stage 2: Instrument loading

The prepared sample is loaded into a disposable or reusable cuvette, capillary cell or microplate well, and the optical bench equilibrates to the target temperature (typically 25°C) before measurement.

Stage 3: Size or particle-count measurement

DLS autocorrelates scattered-light intensity fluctuations, NTA tracks individual particle trajectories on video, or laser diffraction records the angular scattering pattern — each producing the raw data for a size (or size-and-count) distribution.

Stage 4: Zeta potential measurement

An electric field is applied across the sample and the electrophoretic mobility of particles is measured by laser Doppler velocimetry, converting to zeta potential in millivolts — a proxy for colloidal and formulation stability.

Stage 5: Software fitting and reporting

Cumulants or CONTIN algorithms (DLS), Mie-theory inversion (laser diffraction) or trajectory statistics (NTA) convert raw signal to a size/charge/concentration distribution, with 21 CFR Part 11-compliant audit trails for GxP environments.

Stage 6: GxP report and batch disposition

The finished report — Z-average, PdI, zeta potential, or particle concentration — is compared against a validated specification, driving a batch-release, rejection or formulation-adjustment decision.